Policy Webinar 1.
Critical Reflections: The Global AMR Response
Dr Catrin Moore (Oxford University) introduced: (i) Lord Jim O’Neill (Pan-European Commission on Health and Sustainable Development, Chair of the 2014-16 AMR Review, and formerly Goldman Sachs) who addressed antibiotic demand-reducing aspects and supply side issues, as well as focusing on key areas of the challenge in addressing AMR.
- Full recording of the webinar is available here
Policy Webinar 2.
AMR Surveillance: Past, Present and Future
Dr Pascal Ondoa (African Society of Laboratory Medicine) introduced: (i) Dr John Stelling (Co-Director, WHO Collaborating Center for Surveillance of AMR, Brigham and Women’s Hospital in Boston, USA) whose work supports the public health infrastructure for laboratory services, including enhancing routine surveillance; and (ii) Dr David Aanensen (Big Data Institute, University of Oxford, and Director of the Centre for Genomic Pathogen Surveillance) whose work focuses on data flow and use of genome sequencing for surveillance of microbial pathogens.
Policy Webinar 3.
Linking the ‘technical’ and the ‘social’
Dr Will Parks (UNICEF) introduced: (i) Professor Olivier Ruben (Professor of Global Studies at Roskilde University, Denmark), who provided a perspective of the health and social sciences, and the tension between the two paradigms, and the importance of synergies in relation to addressing AMR; and (ii) Professor Claire Chandler (Co-Director of the Antimicrobial Resistance Centre, London School of Hygiene and Tropical Medicine) who described her research on antibiotic use, and the importance of social research for AMR.
Policy Webinar 4.
The Public and the Private sectors: Points of intersection, points of departure
Dr Gemma Buckland-Merrett (Research lead for drug resistant infections, Wellcome Trust) introduced: Dr Catrin Moore (then Research Group Leader, Oxford Global Burden of Disease Project) who described the Global Research on Antimicrobial Resistance (GRAM) which produced health metrics and geospatial maps relating to the global disease burden of AMR; and (ii) Dr Bruce Altevogt (VP/Head of External Medical Engagement in Pfizer’s hospital business unit) who described Pfizer’s involvement in addressing AMR, and the role of public-private partnerships, including the ATLAS surveillance platform.
Policy Webinar 5.
One Health and AMR Surveillance: Approaches and Options
Professor Sabiha Essack (Senior Implementation Research Advisor to ICARS) introduced: (i) Professor Frank Møller Aarestrup (Technical University of Denmark/Head of Division at the National Food Institute) whose research targets the association between the use of antimicrobial agents to farm animals and the emergence and spread of AMR in humans; and (ii) Professor Thomas Van Boeckel (Spatial epidemiologist at ETH Zurich) whose research includes developing maps of AMR and explores economic incentives to reduce AMU in animals.
Policy Webinar 6.
Disruptive methodologies: Artificial Intelligence, Machine Learning, and AMR
Dr John Stelling (WHONet) introduced: Dr Jon Stokes (Asst. Professor, Department of Biochemistry and Biomedical Sciences, McMaster University, Canada) whose work focuses on understanding the relationships between antibiotic structure, bacterial cell physiology, and the extracellular environment; and (ii) Dr Brian Hie (Stanford Science Fellow, Stanford University School of Medicine) who develops algorithms and machine learning methods, with a focus on biological application.